Method for diagnosing thromboembolic disorders and coronary...

Details Method for diagnosing thromboembolic disorders and coronary... Method for diagnosing thromboembolic disorders and coronary...

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2625698

The invention relates to a method for the In-vitro diagnosis of thromboembolic disorders and/or coronary heart diseases. The nucleotide in position 470 of a nucleic acid, coded for human EGLN2-protein, or the amino acid in position 58 of the human EGLN2-protein of a sample from a person is determined.

L'invention concerne un procédé permettant d'effectuer des diagnostics in vitro de maladies thromboemboliques et/ou de maladies cardiaques coronariennes, selon lequel le nucléotide situé en position 470 d'un acide nucléique codant la protéine EGLN2 humaine ou l'aminoacide situé en position 58 de la protéine EGLN2 humaine d'un échantillon prélevé sur un individu est déterminé.

Affiliated with

Also associated with

Rating

Method for diagnosing thromboembolic disorders and coronary... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for diagnosing thromboembolic disorders and coronary..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing thromboembolic disorders and coronary... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1936235